AIRS:NSD-AirSculpt Technologies, Inc. Common Stock (USD)

COMMON STOCK | Medical Care Facilities | NSD

Last Closing Price

USD 10.72

Change

+0.26 (+2.49)%

Market Cap

USD 0.57B

Volume

1.12M

Avg Analyst Target

USD 20.75 (+93.56%)

Avg User Target

USD
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict


AirSculpt Technologies, Inc. Common Stock (AIRS) Stock Analysis:
Based on the AirSculpt Technologies, Inc. Common Stock stock forecasts from 4 analysts, the average analyst target price for AirSculpt Technologies, Inc. Common Stock is USD 20.75 over the next 12 months. AirSculpt Technologies, Inc. Common Stock’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of AirSculpt Technologies, Inc. Common Stock is Slightly Bearish, which is based on 4 positive signals and 6 negative signals. At the last closing, AirSculpt Technologies, Inc. Common Stock’s stock price was USD 10.72. AirSculpt Technologies, Inc. Common Stock’s stock price has changed by -1.33 % over the past week, -4.10 % over the past month and +0.00 % over the last year.

About

AirSculpt Technologies, Inc. focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States. It offers custom body contouring using its AirSculpt procedure that removes unwanted fat in a minimally in ...Read More

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2021-12-03 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
AMEH Apollo Medical Holdings Inc

-13.01 (-14.69%)

USD5.37B 47.06 35.35
ACHC Acadia Healthcare Company Inc

-1.05 (-1.83%)

USD5.05B 47.80 13.90
AMED Amedisys Inc

-5.30 (-3.74%)

USD4.72B 21.27 13.70
ENSG The Ensign Group Inc

-0.90 (-1.18%)

USD4.27B 22.55 16.96
SGRY Surgery Partners Inc

-0.85 (-1.84%)

USD4.06B 63.00 18.01
LHCG LHC Group Inc

-3.50 (-3.05%)

USD3.49B 27.69 14.88
PRSC The Providence Service Corpora..

N/A

USD2.21B 74.23 15.08
ADUS Addus HomeCare Corporation

-4.07 (-4.59%)

USD1.41B 34.40 21.11
CMPS COMPASS Pathways plc

-2.35 (-7.36%)

USD1.37B N/A N/A
AVAH Aveanna Healthcare Holdings In..

-0.04 (-0.63%)

USD1.31B N/A 10.97

ETFs Containing AIRS

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Medical Care Facilities)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization 0.57B 36% F 57% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Medical Care Facilities)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio N/A N/A N/A N/A N/A
Price/Book Ratio 7.41 29% F 17% F
Price / Cash Flow Ratio 40.74 16% F 10% F
EV/EBITDA 19.11 35% F 37% F
Management Effectiveness  
Return on Equity N/A N/A N/A N/A N/A
Return on Invested Capital 6.49% 50% F 69% D+
Return on Assets N/A N/A N/A N/A N/A
Debt to Equity Ratio 25.97% 43% F 53% F
Technical Ratios  
Short Ratio 0.01 100% A+ 100% A+
Short Percent 0.05% 100% A+ 96% A
Beta N/A N/A N/A N/A N/A
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

Discussions

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.

Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.